Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Carmot Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011853
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule hybrid compounds that target Nonalcoholic Steatohepatitis (NASH), protein-protein interactions (NEMO/IKK) for the treatment of cancer and inflammation; and GLP-1R/GIPR for treating Type 2 diabetes and obesity. Carmot Therapeutics proprietary technology, Chemotype Evolution applies to identify and optimize innovative drugs for various therapeutic areas. The company works in collaboration with research institutions and companies such as Amgen Inc and Genentech for discovery of new drugs. Carmot Therapeutics is headquartered in San Francisco, California, the US.

Carmot Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 10
Licensing Agreements 11
Amgen Enters into Licensing Agreement with Carmot Therapeutics 11
Amgen Expands its Licensing Agreement with Carmot Therapeutics 12
Genentech Enters into Licensing Agreement with Carmot Therapeutics 13
Carmot Therapeutics Inc – Key Competitors 14
Carmot Therapeutics Inc – Key Employees 15
Carmot Therapeutics Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Aug 16, 2016: Carmot Therapeutics Appoints Aetna Wun Trombley, Ph.D. to the Board of Directors and Elena Viboch as Director of Business Development and Operations 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Carmot Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 10
Amgen Enters into Licensing Agreement with Carmot Therapeutics 11
Amgen Expands its Licensing Agreement with Carmot Therapeutics 12
Genentech Enters into Licensing Agreement with Carmot Therapeutics 13
Carmot Therapeutics Inc, Key Competitors 14
Carmot Therapeutics Inc, Key Employees 15

★海外企業調査レポート[Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Hong Kong and China Gas Company Limited (3):企業のM&A・提携動向(石油・ガス分野)
    Summary The Hong Kong and China Gas Company Limited (Towngas) is an energy company that produces distributes and markets the gas, water and related activities in Hong Kong and China. The company also carries out the LPG filling stations and utilization of landfill gas. The company has interests in v …
  • Software AG (SOW):企業の財務及び戦略的SWOT分析
    Summary Software AG (SAG) is a technology company that provides software management solutions. The company offers products such as Adabas database management system, ARIS business process analysis platform, ARIS connect, centrasite, mashzone, and ARIS UML Designer. It provides services such as busin …
  • AnaSpec, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AnaSpec, Inc. Mergers and Acqui …
  • Wazee Companies, LLC:企業のM&A・提携動向(発電分野)
    Summary Wazee Companies, LLC (Wazee), a subsidiary of The Timken Company is an industrial goods manufacturer that designs, engineers, manufactures, and markets bearings, transmissions, gearboxes, chain and related products. The company’s pre-engineered crane products include workstation cranes, mono …
  • SK Innovation Co., Ltd.:企業の戦略・SWOT・財務分析
    SummarySK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Sabine Oil & Gas Corporation (SOGC):企業のM&A・提携動向(石油・ガス分野)
    Summary Sabine Oil & Gas Corporation (Sabine Oil), formerly known as Forest Oil Corporation is an independent oil and gas company. The company focuses on acquisition, exploitation, development and exploration of oil and natural gas properties onshore in the US. Its core areas of operations include E …
  • Societe Arabe Internationale de Banque (S.A.E.) (SAIB):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Societe Arabe Internationale de Banque (S.A.E.)" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible for …
  • Broadridge Financial Solutions, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Broadridge Financial Solutions, …
  • CHS Inc. (CHSCP):企業のM&A・提携動向(石油・ガス分野)
    Summary CHS Inc. (CHS) is an integrated agribusiness company, which provides products and services, from initial agricultural inputs such as fuels, crop nutrients, farm supplies and crop protection products, to agricultural outputs that include grains and oilseeds, grain and oilseed processing, rene …
  • Och-Ziff Capital Management Group LLC (OZM):企業の財務及び戦略的SWOT分析
    Summary Och-Ziff Capital Management Group LLC (Och-Ziff Capital) is the leading institutional alternative asset manager. Och-Ziff Capital engages in providing asset management services to diversified institutional investors through its funds. Currently, the company manages four main investment funds …
  • McKinsey & Company, Inc.:戦略・SWOT・企業財務分析
    McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Airgas, Inc.:企業のM&A・提携・投資分析
    Airgas, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Airgas, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Edwards Lifesciences Corp (EW)-医療機器分野:企業M&A・提携分析
    Summary Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products …
  • BG Group plc (BG.):企業のM&A・提携動向(石油・ガス分野)
    Summary BG Group plc (BG Group) is a natural gas producer. The company explores, develops and produces natural gas from its assets across the globe. It also produces and markets oil and other liquid products. The company purchases and supplies LNG to various stake holders in its operating region. BG …
  • Shell Oil Products US:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shell Oil Products US Mergers a …
  • National Rural Utilities Cooperative Finance Corporation:企業の戦略・SWOT・財務分析
    SummaryNational Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providin …
  • TGK-14 OAO:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TGK-14 OAO Mergers and Acquisit …
  • Weifa ASA (WEIFA)-石油・ガス分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • BIG SUN Energy Technology Incorporation (3566):企業概要、財務及び戦略的SWOT分析
    Summary BIG SUN Energy Technology Incorporation (BSETI) is a solar cell manufacturer. The company offers products and services that include mono-crystalline and multi-crystalline silicon solar cells of different sizes and customization services. It also provides c-Si based PV cell products such as P …
  • SEAKR Engineering, Inc.:企業の戦略・SWOT・財務分析
    SummarySEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆